Brief: Cyxone: independent laboratory confirms T20K's ability to prevent and brake multiple sclerosis in animal model

Cyxone AB

10/03/2017 12:03

March 10 (Reuters) - Cyxone AB  CYXO.ST : 
    * Says independent laboratory at Monash University in Australia has verified Cyxones 
development substance T20K's ability to both prevent and brake multiple sclerosis in animal 
model 
 
     
Source text for Eikon:  ID:nBQN3Kq5T6  
     
Further company coverage:  CYXO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))